Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates

Maryam Albaji

Maryam Albaji

Assistant Professor of Pulmonary Diseases

Department Internal Medicine

School of Medicine

Sina Hospital

Tehran University of Medical Sciences

Related Documents

1. Severity of Sars-Cov-2 Reinfection in Vaccinated Healthcare Workers, Iranian Journal of Microbiology (2023)

All Documents

1. Different Sars-Cov-2 Subvariants and Coagulation Markers Trend: A Retrospective Multicentric Study From Iranian Network for Research in Viral Diseases (Inrvd), Health Science Reports (2026)

2. Different Sars-Cov-2 Subvariants and Coagulation Markers Trend: A Retrospective Multicentric Study From Iranian Network for Research in Viral Diseases (Inrvd), Health Science Reports (2026)

3. Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance?, American Journal of Therapeutics (2026)

4. Comparison of Pulmonary Computed Tomography Angiography Findings of Covid-19 Cases With and Without Pulmonary Thromboembolism, Medicine (United States) (2025)

5. The Value of the Galactomannan Test in Diagnosing Covid-19–Associated Pulmonary Aspergillosis: A Review, Iranian Journal of Pathology (2025)

6. Severity of Sars-Cov-2 Reinfection in Vaccinated Healthcare Workers, Iranian Journal of Microbiology (2023)